Healthcare

Techseriesinsight > Blog > News > Healthcare

April 22, 2025
PRNewswire
Healthcare

Angel MedFlight Earns Fourth Consecutive NAAMTA Global Accreditation

NAAMTA Global and Angel MedFlight are pleased to announce the renewal of Angel MedFlight’s accreditation for a fourth consecutive three-year term. This reaccreditation reflects Angel MedFlight’s consistent adherence to the highest standards...

April 17, 2025
PRNewswire
Healthcare

Palatin Reports Positive Appetite Suppression Results From Phase 2 Obesity Study of MC4R Agonist Bremelanotide and Tirzepatide

Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, announced positive appetite suppression results...

April 17, 2025
PRNewswire
Healthcare

Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today announced that a new...

April 14, 2025
PRNewswire
Healthcare

Karmanos Cancer Institute Highlights Symptoms to Not Ignore During Head and Neck Cancer Awareness Month

The Barbara Ann Karmanos Cancer Institute, cancer centers, and other organizations nationwide recognize April as Head and Neck Cancer Awareness Month. Many types of cancers occur in the head and...

April 11, 2025
PRNewswire
Healthcare

IM Cannabis Provides Corporate Updates

IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company”, “IM Cannabis”, or “IMC”), a leading medical cannabis company with operations in Israel and Germany, today announced the following corporate updates. Nasdaq Notification Letter...

April 11, 2025
PRNewswire
Healthcare

OrderlyMeds’ Response to Eli Lilly’s Cease-and-Desist Letter

On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the compounding of Tirzepatide. This is our open response. Prescribers and pharmacists have been taking care of...

April 10, 2025
PRNewswire
Healthcare

MedSpeed Celebrates 25 Years of Transforming Healthcare Logistics

MedSpeed, a leading provider of same-day logistics services to the health care industry, is celebrating its 25th anniversary. With nearly 3,400 employees across 33 states, the company has come a...

April 8, 2025
PRNewswire
Healthcare

Blue Faery Recognizes Excellence in Liver Cancer Research

Blue Faery: The Adrienne Wilson Liver Cancer Association announces the Blue Faery Award (BFA) for Excellence in Liver Cancer Research recipient. Primary liver cancer, also known as Hepatocellular Carcinoma (HCC), remains the...

April 8, 2025
PRNewswire
Healthcare

Dr Crystal Mackall Receives IO360 Lifetime Achievement Award for Pioneering Work in T Cell Therapies

The Conference Forum announced that the Immuno-Oncology 360º (IO360º) Summit honored Crystal Mackall, MD, FAAP, FAACR, Stanford University, with the IO360º Lifetime Achievement Award for her scientific innovation, impact on drug development,...

April 8, 2025
PRNewswire
Healthcare

Alphyn Announces First Patient Dosed in CLEAR-AD1 Global Phase 2b Clinical Trial Program of Zabalafin Hydrogel for Atopic Dermatitis

Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that the first patient has been dosed in its CLEAR-AD1 Phase 2b clinical trial of Zabalafin Hydrogel in Australia. The trial will evaluate...